Scott Welden is currently the Associate Director, Oncology Portfolio Strategy Team Head at Gilead Sciences, where they continue to lead efforts in global oncology clinical development. With a Master of Science in Pharmacology from Thomas Jefferson University, Scott has a strong background in the pharmaceutical industry, previously holding roles such as Associate Director at GSK and Project Manager at Syneos Health. Known for fostering transparent communication and building trusting partnerships, Scott has demonstrated success in guiding cross-functional teams through complex clinical programs, ensuring operational and financial success in clinical trials.
This person is not in the org chart
This person is not in any teams
This person is not in any offices